Marimed (MRMD) Operating Leases (2019 - 2026)

Marimed (MRMD) has 8 years of Operating Leases data on file, last reported at $6.4 million in Q1 2026.

• On a quarterly basis, Operating Leases fell 12.15% year-over-year to $6.4 million in Q1 2026; TTM through Mar 2026 was $6.4 million, a 12.15% decrease from a year earlier, with the FY2025 full-year figure at $6.6 million, down 12.36% from the prior year.
• Operating Leases for Q1 2026 stood at $6.4 million, down from $6.6 million in the prior quarter.
• Over the last five years, Operating Leases for MRMD reached as high as $10.5 million in Q2 2023 and fell as low as $4.2 million in Q4 2022.
• Historically, Operating Leases has averaged $7.3 million across 5 years, with a median of $7.5 million in 2024.
• Across the five-year window, Operating Leases jumped 144.76% in 2023 and slipped 28.54% in 2025, its largest moves.
• Year by year, Operating Leases stood at $4.2 million in 2022, then surged by 102.61% to $8.5 million in 2023, then decreased by 10.72% to $7.5 million in 2024, then retreated by 12.36% to $6.6 million in 2025, then decreased by 3.46% to $6.4 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $6.4 million in Q1 2026, $6.6 million in Q4 2025, and $8.8 million in Q3 2025.